![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 50, 47709-47714, December 14, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Division of Hematology/Oncology, Cedars-Sinai Medical
Center, UCLA School of Medicine, Los Angeles, California 90048 and the
§ Department of Medicine, Hematology and Oncology,
University of Muenster, Muenster 48129, Germany
Cysteine-rich protein 61 (Cyr61) is a
member of a family of growth factor-inducible immediate-early genes. It
regulates cell adhesion, migration, proliferation, and differentiation
and is involved in tumor growth. In our experiments, the role of Cyr61 in non-small cell lung cancer (NSCLC) was examined. Expression of Cyr61
mRNA was decreased markedly in four of five human lung tumor
samples compared with their normal matched lung samples. NSCLC cell
lines NCI-H520 and H460, which have no endogenous Cyr61, formed
60-90% fewer colonies after being transfected with a Cyr61 cDNA
expression vector than cells transfected with the same amount of empty
vector. After stable transfection of a Cyr61 cDNA expression vector, proliferation of both H520-Cyr61 and H460-Cyr61 sublines decreased remarkably compared with the cells stably transfected with
empty vector. The addition of antibody against Cyr61 partially rescued
the growth suppression of both H520-Cyr61 and H460-Cyr61 cells. Cell
cycle analysis revealed that both H520-Cyr61 and H460-Cyr61 cells
developed G1 arrest, prominently up-regulated
expression of p53 and p21WAF1, and had
decreased activity of cyclin-dependent kinase 2. The increase of pocket protein pRB2/p130 was also detected in these cells.
Notably, both of the Cyr61-stably transfected lung cancer cell lines
developed smaller tumors than those formed by the wild-type cells in
nude mice. Taken together, we conclude that Cyr61 may play a role as a
tumor suppressor in NSCLC.
Cyr61, a Member of CCN Family, Is a Tumor Suppressor in Non-Small
Cell Lung Cancer*
,
*
This work was supported by the National Institutes of
Health, the Porka Hugher Fund, Horn Trust, Ko-So Foundation, and the C. and H. Koeffler Fund.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Division of
Hematology/Oncology, Cedars-Sinai Medical Center, Davis Bldg., Rm. 5022, 8700 Beverly Blvd., Los Angeles, CA 90048. Tel.:
310-423-7739; Fax: 310-423-0225, E-mail:
xiangjuntong@hotmail.com.
This article has been cited by other articles:
![]() |
H. Liu, R. Yang, B. Tinner, A. Choudhry, N. Schutze, and B. Chaqour Cysteine-Rich Protein 61 and Connective Tissue Growth Factor Induce Deadhesion and Anoikis of Retinal Pericytes Endocrinology, April 1, 2008; 149(4): 1666 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-R. Lin, C.-C. Chang, L.-R. Chen, M.-H. Wu, M.-Y. Wang, I-H. Kuo, C.-Y. Chu, K.-J. Chang, P.-H. Lee, W.-J. Chen, et al. Cysteine-Rich 61 (CCN1) Enhances Chemotactic Migration, Transendothelial Cell Migration, and Intravasation by Concomitantly Up-Regulating Chemokine Receptor 1 and 2 Mol. Cancer Res., November 1, 2007; 5(11): 1111 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kikuchi, H. Tsuda, Y. Kanai, T. Kasamatsu, K. Sengoku, S. Hirohashi, J. Inazawa, and I. Imoto Promoter Hypermethylation Contributes to Frequent Inactivation of a Putative Conditional Tumor Suppressor Gene Connective Tissue Growth Factor in Ovarian Cancer Cancer Res., August 1, 2007; 67(15): 7095 - 7105. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. MacLaughlan, W. A. Palomino, B. Mo, T. D. Lewis, R. A. Lininger, and B. A. Lessey Endometrial Expression of Cyr61: A Marker of Estrogenic Activity in Normal and Abnormal Endometrium Obstet. Gynecol., July 1, 2007; 110(1): 146 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chien, D. Yin, D. Gui, A. Mori, J. M. Frank, J. Said, D. Kusuanco, A. Marchevsky, R. McKenna, and H. P. Koeffler Suppression of Cell Proliferation and Signaling Transduction by Connective Tissue Growth Factor in Non-Small Cell Lung Cancer Cells Mol. Cancer Res., August 1, 2006; 4(8): 591 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gery, D. Xie, D. Yin, H. Gabra, C. Miller, H. Wang, D. Scott, W. S. Yi, M. L. Popoviciu, J. W. Said, et al. Ovarian Carcinomas: CCN Genes Are Aberrantly Expressed and CCN1 Promotes Proliferation of these Cells Clin. Cancer Res., October 15, 2005; 11(20): 7243 - 7254. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jin, H. P. Kim, E. Ifedigbo, L. F. Lau, and A. M. K. Choi Cyr61 Protects against Hyperoxia-Induced Cell Death via Akt Pathway in Pulmonary Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 297 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Lin, C.-Y. Zuon, C.-C. Chang, S.-T. Chen, C.-P. Chen, B.-R. Lin, M.-Y. Wang, Y.-M. Jeng, K.-J. Chang, P.-H. Lee, et al. Cyr61 Induces Gastric Cancer Cell Motility/Invasion via Activation of the Integrin/Nuclear Factor-{kappa}B/Cyclooxygenase-2 Signaling Pathway Clin. Cancer Res., August 15, 2005; 11(16): 5809 - 5820. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Grotendorst and M. R. Duncan Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation FASEB J, May 1, 2005; 19(7): 729 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Takai, N. Kawamata, C. S. Walsh, S. Gery, J. C. Desmond, S. Whittaker, J. W. Said, L. M. Popoviciu, P. A. Jones, I. Miyakawa, et al. Discovery of Epigenetically Masked Tumor Suppressor Genes in Endometrial Cancer Mol. Cancer Res., May 1, 2005; 3(5): 261 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chien, T. Kumagai, C. W. Miller, J. C. Desmond, J. M. Frank, J. W. Said, and H. P. Koeffler Cyr61 Suppresses Growth of Human Endometrial Cancer Cells J. Biol. Chem., December 17, 2004; 279(51): 53087 - 53096. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Kim, J.-H. Park, S.-K. Chung, J.-Y. Kim, H.-Y. Hwang, K.-C. Chung, I. Jo, S.-I. Park, and J.-H. Nam Coxsackievirus B3 Infection Induces cyr61 Activation via JNK To Mediate Cell Death J. Virol., December 15, 2004; 78(24): 13479 - 13488. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G Jiang, G. Watkins, O. Fodstad, A. Douglas-Jones, K. Mokbel, and R. E Mansel Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer Endocr. Relat. Cancer, December 1, 2004; 11(4): 781 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Chang, J.-Y. Shih, Y.-M. Jeng, J.-L. Su, B.-Z. Lin, S.-T. Chen, Y.-P. Chau, P.-C. Yang, and M.-L. Kuo Connective Tissue Growth Factor and Its Role in Lung Adenocarcinoma Invasion and Metastasis J Natl Cancer Inst, March 3, 2004; 96(5): 364 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. van Ginkel, R. L. Gee, R. L. Shearer, L. Subramanian, T. M. Walker, D. M. Albert, L. F. Meisner, B. C. Varnum, and A. S. Polans Expression of the Receptor Tyrosine Kinase Axl Promotes Ocular Melanoma Cell Survival Cancer Res., January 1, 2004; 64(1): 128 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
A E Bonner, W J Lemon, and M You Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis J. Med. Genet., June 1, 2003; 40(6): 408 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Kim, Y. K. Min, J.-H. Baik, L. F. Lau, B. Chaqour, and K. C. Chung Expression of Angiogenic Factor Cyr61 during Neuronal Cell Death via the Activation of c-Jun N-terminal Kinase and Serum Response Factor J. Biol. Chem., April 11, 2003; 278(16): 13847 - 13854. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Soon, T.-A. Yie, A. Shvarts, A. J. Levine, F. Su, and K.-M. Tchou-Wong Overexpression of WISP-1 Down-regulated Motility and Invasion of Lung Cancer Cells through Inhibition of Rac Activation J. Biol. Chem., March 21, 2003; 278(13): 11465 - 11470. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |